Jumio Named a Representative Vendor in Fifth Consecutive Gartner® Market Guide for Identity Verification
The Market Guide discusses growing concerns about AI-enabled attacks using deepfakes, offers comprehensive market recommendations…
3 years ago
Alex
BYD Launched the U8 Premium Edition Under Its High-End Sub-Brand Yangwang
BYD's high-end sub-brand, Yangwang, officially unveiled the U8 Premium Edition priced at 1,098,000 RMB Yangwang…
3 years ago
WWE® Returns to Australia With Elimination Chamber: Perth
Premium Live Event Scheduled for Saturday, February 24 at Award-Winning Optus Stadium Fans Around the…
3 years ago
Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO® (mogamulizumab) at EORTC 2023.
Systemic therapy approved for second-line treatment of adults with mycosis fungoides (MF) or Sézary syndrome…
3 years ago
SC Ventures Launches audax Financial Technology to Help Financial Institutions Accelerate Digital Banking Capabilities
audax is designed to help banks compete in the digital age, pursue new digital business…
3 years ago
Surge in Production Demand for Solar N-Type Cells Observed as Battery Technology Evolution Accelerates, Says TrendForce
TAIPEI, Taiwan--(BUSINESS WIRE)--#CMC--Leveraging the superior conversion efficiency of N-type cells, the rise of cost-effective TOPCon…
3 years ago
Inuitive Adopts VeriSilicon’s Advanced ISP IP for its Vision AI Processor
VeriSilicon’s IP solutions optimized for demanding Robotics and AR/VR/MR applications SHANGHAI--(BUSINESS WIRE)--#3D--VeriSilicon (688521.SH) today announced…
3 years ago
Atlys Raises $12 Million in Series A
Round led by Peak XV Partners (formerly Sequoia Capital India) and Elevation Capital with participation…
3 years ago
Successful Demonstration of STERRADâ„¢ (Sterilization Equipment) to Run Using Electric Vehicles as Power Source – ASP Japan G.K.
Utilizing EV (Electric Vehicle) Energy for Medical Services at Times of Disaster HAMAMATSU, Japan--(BUSINESS WIRE)--In…
3 years ago
Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia
Partnership with Everest Medicines will address a critical unmet medical need for patients with active…
3 years ago